Key result
BAY K 8644 reduced the amplification factor of DHP/ryanodine receptors by 50% at all potentials in rat ventricular myocytes.
The gain of Ca2+-induced Ca2+ release in cardiac myocytes is regulated by the gating kinetics of L-type Ca2+ channels, and BAY K 8644 suppresses this amplification factor by attenuating Ca2+-dependent inactivation.
No immediate clinical implications; leaves open whether DHP modulation of CICR gain translates to human myocytes or disease models.
The amplification factor of dihydropyridine (DHP)/ryanodine receptors was defined as the amount of Ca2+ released from the sarcoplasmic reticulum (SR) relative to the influx of Ca2+ through L-type Ca2+ channels in rat ventricular myocytes. The amplification factor showed steep voltage dependence at potentials negative to -10 mV but was less dependent on voltage at potentials positive to this value. In cells dialyzed with 0.2 mM cAMP in addition to 2 mM fura 2, the Ca2+-channel agonist (-)-BAY K 8644 enhanced Ca2+-channel current (ICa), shifted the activation curve by -10 mV, and significantly delayed its inactivation. Surprisingly, BAY K 8644 reduced the amplification factor by 50% at all potentials, even though the caffeine-releasable Ca2+ stores were mostly intact at holding potentials of -90 mV. In contrast, brief elevation of extracellular Ca2+ activity from 2 to 10 mM enhanced both ICa and intracellular Ca2+ transients in the absence or presence of BAY K 8644 but had no significant effect on the amplification factor. BAY K 8644 abolished the direct dependence of the rate of inactivation of ICa on the release of Ca2+ from the SR. These findings suggest that the gain of the Ca2+-induced Ca2+ release in cardiac myocytes is regulated by the gating kinetics of cardiac L-type Ca2+ channels via local exchange of Ca2+ signals between DHP and ryanodine receptors and that BAY K 8644 suppresses the amplification factor through attenuation of the Ca2+-dependent inactivation of Ca2+ channels.
No takes yet. Share an insight, caveat, or question.
Adachi‐Akahane et al. (1999) studied this question. BAY K 8644 was evaluated on Amplification factor of DHP/ryanodine receptors. BAY K 8644 reduced the amplification factor of DHP/ryanodine receptors by 50% at all potentials in rat ventricular myocytes.